Document Detail


Neuroprotective strategies to avert seizure-induced neurodegeneration in epilepsy.
MedLine Citation:
PMID:  17571357     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Neurodegeneration in limbic circuits is a hallmark feature of chronic temporal lobe epilepsy (TLE). Studies in experimental animal models and human patients indicate that seizure-induced neuronal injury involves some active, as well as passive cell death processes. Experimental approaches that inhibit active steps in cell death programs have been shown to reduce neuronal cell death and sclerosis, but not to prevent epileptogenesis in animal models of TLE. These findings suggest that we need additional research using both animal models and brain slices from human patients to understand the pathological mechanisms underlying seizure generation. Such comparative studies will also aid in evaluating the potential therapeutic value of inhibiting cell death in seizure disorders.
Authors:
Janice R Naegele
Related Documents :
10427687 - Generation of free radicals during the death of saccharomyces cerevisiae caused by lipi...
16465277 - Programmed cell death during plant growth and development.
12609037 - Changes in hydrogen peroxide homeostasis trigger an active cell death process in tobacco.
18434077 - The broad-spectrum caspase inhibitor boc-asp-cmk induces cell death in human leukaemia ...
19264847 - Enhancement of doxorubicin cytotoxicity on human esophageal squamous cell carcinoma cel...
3497927 - Metabolically inactive 3t3 cells can substitute for marrow stromal cells to promote the...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Epilepsia     Volume:  48 Suppl 2     ISSN:  0013-9580     ISO Abbreviation:  Epilepsia     Publication Date:  2007  
Date Detail:
Created Date:  2007-06-15     Completed Date:  2007-07-17     Revised Date:  2011-09-22    
Medline Journal Info:
Nlm Unique ID:  2983306R     Medline TA:  Epilepsia     Country:  United States    
Other Details:
Languages:  eng     Pagination:  107-17     Citation Subset:  IM    
Affiliation:
Department of Biology, Room 257, Hall-Atwater Laboratory, Lawn Avenue, Wesleyan University, Middletown, CT 06459, USA. janaegele@wesleyan.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Brain / pathology,  physiopathology
Calcium / physiology
Cell Death / physiology
DNA Damage / physiology
DNA Repair / physiology
Disease Models, Animal*
Epilepsy, Temporal Lobe / pathology,  physiopathology*,  therapy*
Gene Therapy
Genes, bcl-1 / physiology
Humans
Models, Neurological
Nerve Degeneration / physiopathology,  prevention & control*
Neuroprotective Agents / therapeutic use*
Rats
Research Design
Seizures* / pathology,  physiopathology
Grant Support
ID/Acronym/Agency:
R01 NS042826-05/NS/NINDS NIH HHS; R01 NS42826/NS/NINDS NIH HHS
Chemical
Reg. No./Substance:
0/Neuroprotective Agents; 7440-70-2/Calcium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neonatal seizures: gaps between the laboratory and the clinic.
Next Document:  Epidemiological study of lung cancer in Portugal (2000/2002)